QYJD Compound Preparation Promotes Rapid Postoperative Recovery in Early-stage NSCLC Patients by Regulating Tissue Microecology: a Prospective, Randomized Controlled, Open-label, Phase I Clinical Study With Predefined Future Exploration is a PHASE1 clinical asset sponsored by Fuzhou General Hospital in NSCLC. SEO and diligence focus: QYJD Compound Preparation, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.